ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ALPN Alpine Immune Sciences Inc

64.615
0.015 (0.02%)
最終更新日: 00:59:21
15分遅延
名称 銘柄コード 市場 種別
Alpine Immune Sciences Inc ALPN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.015 0.02% 64.615 00:59:21
始値 安値 高値 終値 前日終値
64.62 64.58 64.67 64.60
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1205:27PRNUSKuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to..
2024/4/1120:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
2024/4/1105:15BWAlpine Immune Sciences Shares Updated Clinical Data from..
2024/4/1105:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
2024/4/0122:00BWAlpine Immune Sciences to Present Updated Clinical Data for..
2024/3/2120:45BWAlpine Immune Sciences Presents New Translational Data on..
2024/3/2105:30BWAlpine Immune Sciences to Participate in Upcoming H.C...
2024/3/1905:05BWAlpine Immune Sciences Provides Corporate Update and Full..
2024/3/0806:30BWAlpine Immune Sciences to Report Fourth Quarter and Full..
2024/2/2706:30BWAlpine Immune Sciences to Participate in Two Upcoming..
2024/2/1506:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1423:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0806:12EDGAR2Form 8-K - Current report
2024/2/0206:30BWAlpine Immune Sciences to Participate in Two Upcoming..
2024/1/2308:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0608:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0608:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:45EDGAR2Form 8-K - Current report
2024/1/0509:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0509:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2206:23EDGAR2Form 8-K - Current report
2023/12/2206:15BWAlpine Immune Sciences Announces Amendment of Acazicolcept..
2023/12/1906:30BWAlpine Immune Sciences to Present at the 42nd Annual J.P...
2023/11/2300:25EDGAR2Form SC 13D/A - General statement of acquisition of..
2023/11/2106:30BWAlpine Immune Sciences to Participate in the Evercore ISI..
2023/11/1523:00BWAlpine Immune Sciences Presents New Translational Data on..
2023/11/1506:15BWAlpine Immune Sciences Reports Third Quarter 2023 Financial..
2023/11/1323:00BWAlpine Immune Sciences Presents New Translational Data on..
2023/11/0711:41BWAlpine Immune Sciences Announces Pricing of $150 Million..
2023/11/0711:37EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
2023/11/0620:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/0620:02EDGAR2Form 8-K - Current report
2023/11/0620:00BWAlpine Immune Sciences Announces Proposed Public Offering
2023/11/0322:00BWAlpine Immune Sciences Presents New Preclinical Data on..
2023/11/0222:12EDGAR2Form 8-K - Current report
2023/11/0222:00BWAlpine Immune Sciences Presents Initial Clinical Data on..
2023/10/3022:00BWAlpine Immune Sciences to Present New Translational Data on..
2023/10/1322:05BWAlpine Immune Sciences to Present Initial Clinical Data on..
2023/10/0506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0506:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/0421:00BWAlpine Immune Sciences Announces Appointment of Wolfgang..
2023/9/1221:30BWAlpine Immune Sciences Presents First Preclinical Data for..
2023/9/0605:30BWAlpine Immune Sciences to Participate in Two Upcoming..
2023/9/0521:30BWAlpine Immune Sciences to Present First Preclinical Data for..
2023/8/3105:30BWAlpine Immune Sciences Announces Initiation of Dosing in 240..
2023/8/2305:30BWAlpine Immune Sciences Announces Appointment of M. Christina..
2023/8/1713:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/1505:26EDGAR2Form POS AM - Post-Effective amendments for registration..
2023/8/1505:22EDGAR2Form 8-K - Current report
2023/8/1505:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

最近閲覧した銘柄

Delayed Upgrade Clock